Aureka Biotechnologies closed a $100 million Series B on August 10, bringing total funding near $200 million for biological foundation models tied to its Lab-in-the-Loop stack. Granite Asia funded the first tranche alone; a later tranche was led by an unnamed strategic investor with HighLight Capital and follow-ons from MPCi and NRL Capital. Proceeds target larger AuraIDE-class models for de novo design and function prediction, plus tighter single-cell experimental feedback. The California and Shanghai company says OpenDDE ranks near the top of FoldBench checks. The caveat is that the strategic lead remains unnamed and clinical pipeline details stay thin.
Accel closed a $550 million ninth India fund, smaller than its prior $650 million vehicle, as partners say AI applications across consumer, fintech, software and manufacturing are driving the next cycle. About half of Fund VIII remains undeployed, leaving Accel near $1 billion of India dry powder with the new capital. The raise sits inside a $3.5 billion global Accel package that includes $1.35 billion for late-stage bets. Partners told Moneycontrol they still write early cheques near $3 million to $4 million. The caveat is that Accel is chasing applied AI products, so returns hinge on durable margins rather than foundation-model demos.
Anthropic says an unreleased research Claude raised the proven lower bound on nontrivial Riemann zeta zeros on the critical line from 41.6% to 67.2%. Working in Claude Code across two sessions, about 31 million output tokens, and roughly 60 subagents, it found the result after a staff prompt to attempt the Riemann hypothesis. Anthropic mathematicians checked the argument, experts Brian Conrey and Dan Goldston examined it, and Claude produced a Lean formalization. Why it matters: a frontier model moved a real analytic number theory constant, not a contest puzzle. Caveat: this is not a Riemann hypothesis proof, and journal peer review is still ahead.
Meta will publish weights for Muse Spark 1.2, its latest flagship model, CEO Mark Zuckerberg said as the company also shipped Muse Glimmer for local devices, CNBC reported. His essay argued American open-weight labs need looser training-data rules to compete with Chinese releases, and warned that blocking foreign open models is the wrong fix. Muse Spark 1.2 is already available via Meta's Model API and the Muse Code agent. Why it matters: a downloadable US frontier-class model would give enterprises an alternative to Chinese open weights. Caveat: the weights are promised, not posted yet, and future opens will face Meta's new director-led safety criteria.
MeitY told Parliament that amended IT Rules require intermediaries to remove unlawful content within three hours of a valid government or court intimation, down from 36 hours, The Economic Times reported from a Lok Sabha reply by Jitin Prasada. Permissible AI-generated media must carry clear labels and traceable metadata, while sensitive impersonation or nudity grievances shrink to two hours. Platforms must also deploy technical measures against illegal synthetic content, with safe harbour at risk for noncompliance. Why it matters: India's deepfake clock just got much shorter for large intermediaries. Caveat: enforcement will turn on SAHYOG orders and detection quality, not deadlines alone.
AI agent security startup Zenity closed a $125 million Series C led by Norwest, with SoftBank Vision Fund 2, Qumra Capital, Hitachi Ventures, LG Technology Ventures, and prior backers including Vertex and Intel Capital, the company said. Zenity claims it can allow, modify, or block agent actions across Copilot, ChatGPT Enterprise, Gemini, Claude, Codex, Cursor, and custom stacks in Bedrock, Foundry, and Vertex AI. It employs more than 230 people between Tel Aviv and New York. Why it matters: capital is shifting toward runtime control of autonomous agents. Caveat: vendor-reported revenue growth still needs independent verification as the category crowded.
Bengaluru and San Francisco AI coding startup Emergent raised $130 million Series C at a $1.5 billion valuation, TechCrunch reported. Creaegis led, with Claypond, Sentinel Global, and existing backers Khosla Ventures, SoftBank Vision Fund 2, Lightspeed, and Y Combinator joining. Total funding reaches about $230 million after a January Series B. Emergent says users built more than 12 million apps on its vibe coding platform and cites roughly $120 million ARR. Why it matters: India now has another AI application unicorn selling globally, not only sovereign model bets. Caveat: the July print is weeks old, and retention must match flashy app counts.
Alibaba opened a public beta of Wan 3.0 on Alibaba Cloud Model Studio and Qwen Cloud, its community blog said. The Tongyi video model natively generates clips up to 30 seconds, double the Wan 2.7-Video ceiling, and can ingest text, images, video, audio, web pages, and documents such as PDFs and PowerPoint decks. Alibaba pitches unbroken camera moves, tighter character consistency, and marketing or simulation uses. Why it matters: document-to-video can turn slide decks into draft footage without a separate storyboard stack. Caveat: the beta remains a hosted China-region service, so access and export quality still decide adoption.
Tianjin University researchers describe REAP in Nature Communications: a closed-loop enzyme platform that pairs robots with RankReg, a hybrid loss optimizing ranking and numeric fit from sparse lab feedback. It hunts catalytic and distal mutation hotspots, then expands from single edits to combinatorial variants. On cytochrome P450 BM3 it delivered a 57-fold activity gain in five cycles, and on Staphylococcus aureus Sortase A up to 104-fold. Why it matters: ranking-aware active learning may make AI biocatalyst campaigns repeatable outside specialist labs. Caveat: authors filed Chinese patents on the system, and generality beyond these enzymes is unproven.
Writing in npj Breast Cancer, researchers present IICM+, which blends clinicopathologic data, transcriptomics, and multiscale pathology embeddings to predict distant recurrence in HR-positive, HER2-negative, node-negative early breast cancer. Trained on TAILORx cases (n=2808) and tested on a holdout set (n=1621), it reached a C-index of 0.735 for overall distant recurrence and a high-versus-low hazard ratio of 5.25, remaining prognostic after adjustment for recurrence score. Why it matters: slides may refine chemo choices where gene assays leave discordant risk. Caveat: holdout results are not a prospective trial, and Caris employees coauthored the study.
Bengaluru CRM startup Superleap raised Rs 36 crore from Peak XV Partners' Surge to deepen AI product work, hire, and expand India and overseas sales, CEO Subham Kumar Boundia told The Economic Times. Founded in 2024 by former Unacademy executives, it sells AI-native CRM that helps large firms leave legacy systems of record. Superleap says it serves more than 50 enterprises, with typical contracts of $60,000 to $100,000, and names Razorpay and Cars24 among customers. Why it matters: Indian buyers are funding agentic revenue stacks, not another chatbot pilot. Caveat: beating Salesforce-class installs still needs proven migration safety and revenue lift.
In a Lok Sabha reply, IT minister of state Jitin Prasada said India sanctioned 93.18 lakh GPU hours for 237 IndiaAI projects and ordered a roughly 1.1 EFLOPS AI system for NIC's Shastri Park centre in Delhi. Twenty indigenous foundation model bids stay supported, with 15 compute providers empanelled. Semicon India has cleared 12 manufacturing projects worth about Rs 1.64 lakh crore, and Semicon 2.0 adds a Rs 1.27 lakh crore Cabinet outlay. Why it matters: sovereign models need public compute and local silicon together. Caveat: purchase orders still must become installed capacity and trained models.